Stendra, A New Viagra Competitor is About to Hit the Market

A new ED medication is set to roll out next year.

A new ED medication is set to roll out next is about to come out.

Viagra has been around for 15 years. The little blue pill made big waves in the sexual world, eliminating the stigma associated with male impotence. Since Viagra was released, four other medications have followed. Now, for the first time in two years, another ED drug is about to hit the market.

What sets this pill apart?

The biggest benefit of Avanafil, also know as Stendra, is that it works fast. Clinical trials show the medication taking effect in as little as 15 minutes. That’s faster than Viagra.

One doctor predicts the fast-acting pill will be a hit.

“Men who have a pattern of sexual activity that’s predictable — every Saturday night, or something like that, don’t need this. Those whose opportunities for sexual activity are more casual will like it,” said Dr. Ira Sharlip, a urology professor at UC San Francisco and former president of the International Society for Sexual Medicine tells ABC News.

“If you see that things are heading in that direction, you pop a pill and are ready in 15 minutes, if correct.”

The last ED drug to be approved by the FDA was Staxyn in 2010.

The last ED drug to be approved by the FDA was Staxyn in 2010.

Do we really need another ED pill on the market?

There are already a variety of erectile dysfunction medications on the market, but the additional competition could drive prices of other name brand medications, like Viagra and Cialis, down.

“Competition is good. We need to see a reduction in the cost to the consumer of these drugs, and this is not exactly another Viagra,” Sharlip said.

When will Stendra be available?

The FDA set an April 29 target date for its Avanafil review. FDA approval is needed before release, but shorty after the approval process the medication should be available.

We specializes in providing our over 500,000 customers with relevant product and condition information created by our professional editorial staff which includes our team of medical writers, medical practitioners and health educators. Staff on Facebook